Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea Capsules Compared to Placebo After an Initial 12 Week Treatment Regimen With Oracea and MetroGel 1% in Adults With Rosacea.

Trial Profile

Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea Capsules Compared to Placebo After an Initial 12 Week Treatment Regimen With Oracea and MetroGel 1% in Adults With Rosacea.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Aug 2014

At a glance

  • Drugs Doxycycline hyclate (Primary) ; Metronidazole
  • Indications Bacterial infections; Rosacea
  • Focus Therapeutic Use
  • Sponsors Galderma
  • Most Recent Events

    • 08 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 19 Jun 2013 Planned End Date changed from 1 Jan 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
    • 25 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top